AI – Page 2 – Medxy AI

Precision Rehabilitation: Machine Learning Reveals Why ‘Early Mobilization’ Fails Some ICU Patients While Saving Others

By MedXY 12/26/2025

A secondary analysis of the TEAM trial using machine learning demonstrates that enhanced early mobilization in mechanically ventilated patients has highly individualized effects, ranging from a 34% mortality reduction to a 39% increase in risk, depending on baseline clinical characteristics.

AI Cardiology news Rheumatology

AI-Detected Coronary Calcium Significantly Predicts Cardiovascular Risk in Patients with Immune-Mediated Inflammatory Diseases

By MedXY 12/25/2025

AI-driven analysis of routine chest CTs reveals that coronary artery calcium is highly prevalent and strongly predictive of MACE and mortality in patients with IMIDs, identifying a critical treatment gap in this high-risk population.

AI Clinical Updates Infectious Diseases news Public Health

Efficacy of mHealth Interventions for Smoking Cessation in Tuberculosis Patients: Insights from a Cluster Randomized Clinical Trial

By MedXY 12/24/2025

An mHealth text messaging intervention significantly improves smoking cessation rates and reduces mortality among TB patients compared to usual care, supporting its implementation in TB programs.

AI news Psychiatry

Rule-Based Chatbots Outperform LLMs in Depressive Symptom Management: A Systematic Review and Meta-Analysis

By MedXY 12/23/2025

A comprehensive meta-analysis indicates that rule-based chatbots provide a modest but statistically significant reduction in depressive symptoms within a 4-8 week window, whereas evidence for the clinical efficacy of Large Language Model (LLM)-based chatbots remains insufficient due to high variability.

AI Hematology-Oncology news Oncology

Standardizing the Digital Signal: How an Ontology of Early Warning Signs Can Predict Cytokine Release Syndrome

By MedXY 12/21/2025

This article explores a landmark mixed-methods study establishing a digital biomarker ontology for the early detection of Cytokine Release Syndrome (CRS). By identifying core physiological markers, researchers aim to transform immunotherapy safety through continuous monitoring and predictive modeling.

AI Clinical Updates news Psychiatry

Digital Cognitive Behavioral Therapy for Generalized Anxiety Disorder: Evidence, Impact, and Future Directions

By MedXY 12/21/2025

Recent robust randomized trials demonstrate that smartphone-delivered digital cognitive behavioral therapy provides significant, sustained improvements in generalized anxiety disorder, overcoming key access barriers and highlighting its potential for large-scale public health impact.

AI Neurology news

AI-Driven Imaging Decision Support Doubles Thrombectomy Rates in Real-World Stroke Care

By MedXY 12/19/2025

A large-scale prospective study across England's NHS reveals that AI imaging software significantly boosts endovascular thrombectomy rates for acute stroke patients. Implementation was associated with a 100% relative increase in treatment at evaluation sites, highlighting AI's potential to bridge gaps in emergency neurointerventional care.

AI news Rheumatology

Digital Psychological Intervention Reduces Distress and Improves Quality of Life in Inflammatory Rheumatic Diseases: Results from a Pilot RCT

By MedXY 12/14/2025

A 102-participant pilot RCT in Germany found that a self-guided digital psychological intervention produced clinically meaningful reductions in psychological distress and modest improvements in quality of life at 3 months in people with inflammatory rheumatic diseases.

AI Critical Care news

Automated Real‑Time Deterioration Alerts Cut In‑Hospital Cardiac Arrests — What Clinicians Need to Know

By MedXY 12/09/2025

A systematic review and meta-analysis finds that real‑time automated clinical deterioration alert systems reduce in‑hospital cardiac arrests and may shorten ICU stay, but mortality benefits are uncertain and higher‑quality trials are needed.

AI Cardiology Clinical Updates news

Artificial Intelligence-Enabled Prediction of Heart Failure Risk From Single-Lead Electrocardiograms: A Multinational Cohort Review

By MedXY 12/05/2025

This review evaluates AI algorithms predicting heart failure risk from noisy single-lead ECGs, synthesizing evidence from large multinational cohorts, highlighting improved risk stratification with AI-ECG models beyond traditional clinical scores.

AI Cardiology news

AI-Enhanced ECG Predicts Future Regurgitant Valvular Disease: Large International Study Shows Promise for Earlier Detection and Targeted Echocardiography

By MedXY 12/01/2025

An international study developed AI-ECG models that diagnose and predict future moderate–severe mitral, tricuspid, and aortic regurgitation, validated across distinct populations and linked to subclinical chamber remodelling.

AI news Rheumatology

Deep learning classifies focus score and Sjögren’s disease from minor salivary gland biopsies and highlights a CD8+ acinar pattern

By MedXY 12/01/2025

A multicentre deep‑learning model reliably classified biopsy focus score and ACR‑EULAR–defined Sjögren’s disease (AUROC ≈0.88–0.89) and identified a novel CD8+ T‑cell peri‑acinar pattern associated with disease; prospective validation is needed.

AI news Ophthalmology

Foundation Models Narrow the Knowledge Gap in Ophthalmology but Struggle with Images

By MedXY 11/25/2025

Contemporary foundation models match experts on text-only ophthalmology exam questions but underperform on image-based items; targeted multimodal training and prospective validation are needed before clinical deployment.

AI news Oncology

Therapist-Guided e‑Health Cuts Fear of Cancer Recurrence in Colorectal Survivors: A Randomized Trial Shows Clinically Meaningful Benefits

By MedXY 11/19/2025

A Danish RCT of TG‑iConquerFear, a 10‑week therapist‑guided online program for colorectal cancer survivors with clinical fear of cancer recurrence (FCR), reduced FCR scores substantially compared with augmented self‑help at 3 months; the between‑group effect was clinically meaningful (Cohen d 0.62).

AI news Otorhinolaryngology

Deep Learning in Otolaryngology: Promises, Performance, and Pathways to Clinical Use

By MedXY 11/19/2025

This critical synthesis of a 2020–2025 narrative review (327 DL studies) evaluates deep learning (DL) applications across diagnosis, prognosis, segmentation, and emerging intraoperative uses in otolaryngology and outlines practical steps for safe, equitable implementation.

AI Cardiology news

AI-Augmented Screening Triples Detection Yield of Transthyretin Cardiac Amyloidosis in a Multisite Real-World Trial

By MedXY 11/18/2025

An AI-driven screening program (ATTRACTnet) applied to ECG, echocardiography, demographics and orthopedic history substantially increased case detection of transthyretin cardiac amyloidosis (ATTR‑CM) and led to rapid treatment initiation in a target population.

AI Diabetes & Endocrinology news

Stepped Care Plus Cash Incentives Cuts 3‑Year Diabetes Incidence in Multiethnic Asian Prediabetes Cohort

By MedXY 11/17/2025

The Pre-DICTED randomized trial found a stepped-care diabetes prevention program augmented with financial incentives reduced 3‑year diabetes conversion (34.8% vs 47.3%; adjusted RR 0.74), with metformin added for persistent high-risk participants and modest increased adverse events largely from GI symptoms.

AI Gastroenterology news

Does AI Make Endoscopists Lazy? New Multicentre Data Show Reduced Adenoma Detection After AI Exposure

By MedXY 11/09/2025

A multicentre observational study reports a 6% absolute fall in adenoma detection rate for non‑AI colonoscopies after clinicians were exposed to AI-assisted polyp detection—raising concerns about endoscopist deskilling and the need for safeguards.

AI news Orthopedics

Wearable Monitoring Shows Sustained Increases in Daily Activity After Total Knee Arthroplasty, with a 6‑Month Recovery Window

By MedXY 11/05/2025

A prospective cohort using Apple Watch data demonstrated meaningful increases in step count, standing time and gait speed after unilateral total knee arthroplasty, peaking at 6 months and persisting at 12 months.

AI Internal Medicine news

How Eli Lilly and NVIDIA’s AI Supercomputer is Revolutionizing Drug Discovery

By MedXY 11/04/2025

Eli Lilly and NVIDIA have partnered to launch the largest AI-powered supercomputing platform in pharma, aiming to accelerate drug discovery, personalize medicine, and enhance manufacturing through unprecedented computational power.